Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 6, 1996 - Issue 10
Submit an article Journal homepage
9
Views
9
CrossRef citations to date
0
Altmetric
Research

Editorial Central & Peripheral Nervous Systems: Dopamine D1 receptor agonists and dopamine reuptake blockers: new treatment stratagems for Parkinson's disease

Ronald KB Pearce Pharmacology Group, King's College London, Manresa Road, London, SW3 6LX, UK
Pages 949-953 | Published online: 29 Feb 2008

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Alessandra Napolitano, Alessandro Pezzella, Giovanna Misuraca & Giuseppe Prota. (1998) New directions in Parkinson’s research and treatment. Expert Opinion on Therapeutic Patents 8:10, pages 1251-1268.
Read now

Articles from other publishers (8)

Gang Zhao, Zhi-Hua Jiang, Xiang-wei Zheng, Shao-Yun Zang & Li-He Guo. (2008) Dopamine transporter inhibitory and antiparkinsonian effect of common flowering quince extract. Pharmacology Biochemistry and Behavior 90:3, pages 363-371.
Crossref
Jana Hennemann, Wolfgang Schatton & Ralf H. Lyssy. 2000. Ullmann's Encyclopedia of Industrial Chemistry. Ullmann's Encyclopedia of Industrial Chemistry.
Matthew J. Hansard, Lance A. Smith, Michael J. Jackson, Sharon C. Cheetham & Peter Jenner. (2004) The monoamine reuptake inhibitor BTS 74 398 fails to evoke established dyskinesia but does not synergise with levodopa in MPTP-treated primates. Movement Disorders 19:1, pages 15-21.
Crossref
Matthew J Hansard, Lance A Smith, Michael J Jackson, Sharon C Cheetham & Peter Jenner. (2002) Dopamine reuptake inhibition and failure to evoke dyskinesia in MPTP-treated primates. European Journal of Pharmacology 451:2, pages 157-160.
Crossref
Ronald K.B. Pearce, Lance A. Smith, Michael J. Jackson, Tara Banerji, Jorgen Scheel-Krüger & Peter Jenner. (2002) The monoamine reuptake blocker brasofensine reverses akinesia without dyskinesia in MPTP-treated and levodopa-primed common marmosets. Movement Disorders 17:5, pages 877-886.
Crossref
Wolfgang Schatton & Ralf H. Lyssy. 2000. Ullmann's Encyclopedia of Industrial Chemistry. Ullmann's Encyclopedia of Industrial Chemistry.
Ronald K. B. Pearce, Tara Banerji, Peter Jenner & C. David Marsden. (2004) De novo administration of ropinirole and bromocriptine induces less dyskinesia than L ‐dopa in the MPTP‐treated marmoset . Movement Disorders 13:2, pages 234-241.
Crossref
Michael Williams, Stephen Wright & G. Kenneth Lloyd. (1997) Improved therapies for Parkinson's disease: life beyond dopamine D2D3 receptors agonists. Trends in Pharmacological Sciences 18:4, pages 307-310.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.